IMUX - Immunic Q3 2023 Earnings Preview
2023-11-13 13:12:56 ET
More on Immunic
- Immunic: Latest CALLIPER Data Reinforces Vidofludimus Calcium For Multiple Sclerosis
- Immunic jumps after the bell on positive interim data from phase 2 CALLIPER trial
- Seeking Alpha’s Quant Rating on Immunic
- Historical earnings data for Immunic
- Financial information for Immunic
For further details see:
Immunic Q3 2023 Earnings Preview